我国成人非酒精性脂肪性肝病患病率的meta分析

职业与健康 ›› 2023, Vol. 39 ›› Issue (21): 3000-3003.

我国成人非酒精性脂肪性肝病患病率的meta分析

张金俊^1,2, 吕梦¹, 陈浩³, 于海笑², 张淑香¹

1.山东第一医科大学第一附属医院（山东省千佛山医院）护理学,山东济南 250014;
2.山东第一医科大学（山东省医学科学院）护理学院,山东泰安 271016;
3.潍坊医学院护理学院,山东潍坊 261053

收稿日期:2023-03-31 修回日期:2023-04-24 出版日期:2023-11-01 发布日期:2026-03-26
通信作者: 张淑香,主任护师,E-mail：zsx6551@126.com
作者简介:张金俊,女,在读硕士研究生,研究方向为临床护理。
基金资助:
2021年校级教育教学改革研究项目（2021XY084）; 老年医学学会2021年科技攻关计划项目（LKJGG2021Y023）

Prevalence of non-alcoholic fatty liver disease in Chinese adults：A meta-analysis

ZHANG Jinjun^1,2, LYU Meng¹, CHEN Hao³, YU Haixiao², ZHANG Shuxiang¹

1. Nursing Department,First Affiliated Hospital of Shandong First Medical University（Shandong Provincial Qianfoshan Hospital）,Ji'nan Shandong 250014,China;
2. School of Nursing,Shandong First Medical University（Shandong Academy of Medical Sciences）,Taian Shandong 271016,China;
3. School of Nursing,Weifang Medical University,Weifang Shandong 261053,China

Received:2023-03-31 Revised:2023-04-24 Online:2023-11-01 Published:2026-03-26
Contact: ZHANG Shuxiang,Chief nurse,E-mail：zsx6551@126.com

摘要/Abstract

摘要： 目的系统评价我国成人非酒精性脂肪性肝病的患病率情况。方法检索PubMed、 The Cochrane Library、Web of science、中国知网、维普、万方、CBM数据库2012年1月—2022年3月关于我国成人非酒精性脂肪性肝病患病率的中英文研究。应用Stata1 5.0软件进行meta分析,按照性别、地区、年份进行亚组分析。结果我国成人非酒精性脂肪性肝病患病率为32%（95%CI：27%~36%）。亚组分析结果显示,男性患病率为36%高于女性的23%,南方地区患病率为34%高于北方地区的28%,2017—2021年患病率为32%高于2012—2016年患病率的31%。结论我国成人非酒精性脂肪性肝病患病率较高,应加强防治措施,降低非酒精性脂肪性肝病的患病率。

关键词: 非酒精性脂肪性肝病, 患病率, Meta分析

Abstract: Objective To systematically evaluate the prevalence of nonalcoholic fatty liver disease in Chinese adults. Methods The Chinese and English studies on the prevalence of nonalcoholic fatty liver disease in Chinese adults were searched in PubMed,The Cochrane Library,Web of Science,CNKI,VIP,Wanfang and CBM databases from January 2012 to March 2022. The Stata15.0 software was used for meta-analysis,and subgroup analysis was conducted by gender,region and year. Results The prevalence of nonalcoholic fatty liver disease in Chinese adults was 32%（95%CI：27%-36%）. The subgroup analysis showed that the prevalence in males（36%） was higher than that in females（23%）,the prevalence in southern region（34%） was higher than that in northern region（28%）,and the prevalence in 2017-2021（32%） was higher than that in 2012-2016（31%）. Conclusion The prevalence of nonalcoholic fatty liver disease in adults is high in China,so the prevention and treatment measures should be strengthened to reduce the prevalence of nonalcoholic fatty liver disease.

Key words: Nonalcoholic fatty liver disease, Prevalence, Meta-analysis

中图分类号:

R181.2

张金俊, 吕梦, 陈浩, 于海笑, 张淑香. 我国成人非酒精性脂肪性肝病患病率的meta分析. [J]职业与健康, 2023, 39(21): 3000-3003.

ZHANG Jinjun, LYU Meng, CHEN Hao, YU Haixiao, ZHANG Shuxiang. Prevalence of non-alcoholic fatty liver disease in Chinese adults：A meta-analysis. [J]OCCUPATION AND HEALTH, 2023, 39(21): 3000-3003.

参考文献

[1] CHALASANI N,YOUNOSSI Z,LAVINE J E,et al.The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases[J].Hepatology,2018,67(1):328-357.
[2] YOUNOSSI Z M.Non-alcoholic fatty liver disease-A global public health perspective[J].J Hepatol,2019,70(3):531-544.
[3] POWELL E E,WONG V W,RINELLA M.Non-alcoholic fatty liver disease[J].Lancet,2021,397(10290):2212-2224.
[4] WONG S W,CHAN W K.Epidemiology of non-alcoholic fatty liver disease in Asia[J].Indian J Gastroenterol,2020,39(1):1-8.
[5] 曾宪涛,刘慧,陈曦,冷卫东.Meta分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志,2012,4(4):297-299.
[6] 陈芳,尚河颖,刘芳,等.济南铁路局职工非酒精性脂肪肝的发病情况及相关的影响因素[J].当代医药论丛,2018,16(5):144-146.
[7] FUNG J,LEE C K,CHAN M,et al.High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census[J].Liver Int,2015,35(2):542-549.
[8] YI M,CHEN R P,YANG R,et al.Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China[J].Diabet Med,2017,34(4):505-513.
[9] HU X,HUANG Y,BAO Z,et al.Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units[J].BMC Gastroenterol,2012,12:123.
[10] 吴梓苗,冯杰,张爱军.浙江省慈溪市企事业单位人员非酒精性脂肪肝患病率及危险因素分析[J].疾病监测,2014,29(8):660-664.
[11] 王宏伟,曹丽丽,胡寒冰,等.平顶山市矿区非酒精性脂肪肝的患病率及危险因素[J].世界华人消化杂志,2013,21(32):3561-3565.
[12] LU Z Y,SHAO Z,LI Y L,et al.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population:An 8-year follow-up study[J].World J Gastroenterol,2016,22(13):3663-3669.
[13] 路青玲,王婷,张海东,等.宁夏泾源县非酒精性脂肪性肝病的患病率及其危险因素调查[J].中华健康管理学杂志,2018,12(3):237-242.
[14] 望长记,杨咏梅,陈雪媛.粤北山区非酒精性脂肪肝的患病率及相关影响因素分析[J].临床医学工程,2016,23(1):123-124.
[15] 李雅丽,何鹏义,周晶,等.乌鲁木齐地区非酒精性脂肪肝患病率及危险因素分析[J].中国临床保健杂志,2017,20(5):574-578.
[16] 胡玲,李宇.中老年体检人群非酒精性脂肪肝患病率调查及与代谢相关因素的相关性[J].实用医学杂志,2017,33(4):632-635.
[17] 葛辉,陈君,孙毅明,等.广州市健康体检人群非酒精性脂肪肝患病情况及相关危险因素分析[J].中华医学杂志,2016,96(46):3706-3709.
[18] 尚红光,卫俊峰,陈秋生,等.2015年河北省某国有煤矿企业职工非酒精性脂肪肝的流行病学调查[J].职业与健康,2018,34(2):196-199.
[19] 丁芳,秦雨萌,曹群英,等.咸宁市健康体检人群非酒精性脂肪肝病的分布特征及危险因素分析[J].护理研究,2017,31(4):490-492.
[20] 王春萍,修桂英.长春地区健康体检人群中非酒精性脂肪肝的患病率及危险因素分析[J].中国药物经济学,2016,11(11):139-141.
[21] 帅建,匡爱霞,王忠莉,等.武汉某社区老年人非酒精性脂肪肝的流行病学特点及危险因素分析[J].武汉大学学报(医学版),2019, 40(5):796-800.
[22] 徐静远,邵勇,鲁晓岚,等.老年居民非酒精性脂肪性肝病的影响因素和死因分析[J].中华肝脏病杂志,2019,27(3):204-209.
[23] 黄玲玉,孙东,蒋本君,等.天津市某区域体检人群非酒精性脂肪肝调查分析[J].医学信息(西安),2019(4):99-103.
[24] ZENG J,YANG R X,SUN C,et al.Prevalence,clinical characteristics,risk factors,and indicators for lean Chinese adults with nonalcoholic fatty liver disease[J].World J Gastroenterol,2020,26(15):1792-1804.
[25] HU X Y,LI Y,LI L Q,et al.Risk factors and biomarkers of non-alcoholic fatty liver disease:An observational cross-sectional population survey[J].BMJ Open,2018,8(4):e19974.
[26] LIN S,XIAN Y,LIU Y,et al.Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi,China[J].Medicine (Baltimore),2018,97(9):e21.
[27] 章雅南,刘奕婷.沈阳市健康体检人群非酒精性脂肪肝患病情况及影响因素[J].公共卫生与预防医学,2019,30(3):67-70.
[28] 姚晓琴,刘玉萍,王林,等.四川省60岁及以上体检人群非酒精性脂肪性肝病患病率及其与代谢危险因素的相关性[J].中国老年学杂志,2021,41(12):2523-2526.
[29] 张婷,谢雪,刘玉萍,等.四川地区中老年体检人群非酒精性脂肪性肝病患病率调查及与代谢相关指标的相关性分析[J].现代预防医学,2020,47(12):2267-2271.
[30] 朱瑞华,何展明,陈清.广州市某社区老年人非酒精性脂肪肝患病状况及危险因素分析[J].热带医学杂志,2021,21(6):803-806.
[31] 诸葛瑾慧,苏银霞,张明琛,等.新疆柯尔克孜族成人非酒精性脂肪肝病患病率及临床特征分析[J].公共卫生与预防医学,2021,32(5):33-37.
[32] 刘玲娇,余湘尤,虢小丽.西安市职业人群非酒精性脂肪性肝病患病率及其危险因素调查研究[J].陕西医学杂志,2021,50(1):107-110.
[33] 吕曼. 北京西城区某社区老年人非酒精性脂肪肝患病现状及相关危险因素分析[J].健康之友,2021(2):115-116.
[34] 黄海燕,韦荣新,何广营,等.深圳地区出租车司机非酒精性脂肪性肝病患病现状分析[J].临床肝胆病杂志,2020,36(3):612-615.
[35] 夏换兰,陆标明,何凤平,等.佛山市三水区体检人群非酒精性脂肪肝流行病学调查及相关危险因素分析[J].解放军预防医学杂志,2020,38(1):50-52.
[36] 周云庆,徐昱,秦燕,等.上海某社区老年人非酒精性脂肪肝的患病情况及影响因素分析[J].上海医药,2020,41(6):55-58.
[37] 胡晓娜,黄一沁,王姣锋,等.上海地区中老年人不同程度非酒精性脂肪性肝病的流行病学分析[J].老年医学与保健,2020,26(2):191-194.
[38] 仝小玲,张连文.中青年人群非酒精性脂肪肝患病现状及影响因素分析[J].解放军预防医学杂志,2021,39(1):70-72.
[39] 夏祖宇,黄夕夏,熊文坚,等.上海市某社区老年人非酒精性脂肪性肝病患病率及危险因素分析[J].老年医学与保健,2021,27(5):987-993.
[40] LI Z,XUE J,CHEN P,et al.Prevalence of nonalcoholic fatty liver disease in mainland of China:A meta-analysis of published studies[J].J Gastroenterol Hepatol,2014,29(1):42-51.
[41] HUANG T D,BEHARY J,ZEKRY A.Non-alcoholic fatty liver disease:A review of epidemiology,risk factors,diagnosis and management[J].Intern Med J,2020,50(9):1038-1047.
[42] CHEN K L,MADAK-ERDOGAN Z.Estrogens and female liver health[J].Steroids,2018,133:38-43.
[43] 范建高,周琪,沃千红.人体质量指数及其变化与非酒精性脂肪性肝病发病的关系[J].中华肝脏病杂志,2010,18(9):676-679.
[44] WONG V W,WONG G L,YEUNG D K,et al.Incidence of non-alcoholic fatty liver disease in Hong Kong:A population study with paired proton-magnetic resonance spectroscopy[J].J Hepatol,2015,62(1):182-189.
[45] ZHOU Y J,LI Y Y,NIE Y Q,et al.Natural course of nonalcoholic fatty liver disease in southern China:A prospective cohort study[J].J Dig Dis,2012,13(3):153-160.
[46] PERUMPAIL B J,KHAN M A,YOO E R,et al.Clinical epidemiology and disease burden of nonalcoholic fatty liver disease[J].World J Gastroenterol,2017,23(47):8263-8276.
[47] COTTER T G,RINELLA M.Nonalcoholic fatty liver disease 2020:The state of the disease[J].Gastroenterology,2020,158(7):1851-1864.
[48] KWOK R,CHOI K C,WOMG G L,et al.Screening diabetic patients for nonalcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements:A prospective cohort study[J].Gut,2016,65(8):1359-1368.